Johnson & Johnson‘s (NYSE:JNJ) Auris Health touted this week interim results from an independent feasibility study designed to assess the company’s Monarch robotic bronchoscopy technology. The Monarch Platform was cleared by the FDA in March 2018 for diagnostic and therapeutic bronchoscopic procedures. The study was set up to test the safety and feasibility of performing […]
5 ways medtech research aims to help veterans
As the United States prepares to honor its war dead on Memorial Day, medtech researchers are working to help survivors wounded in battle, both in body and mind. Whether the research comes out of government, industry or academia, there’s also a desire to help veterans facing other health challenges. The work is evolving. 3D printing […]
Report: Google AI improves lung cancer diagnosis accuracy
Google (NSDQ:GOOG) has unveiled a new artificial intelligence system that outperformed six radiologists in detecting lung cancer, identifying 5% more cancers and cutting false positive rates by 11%, according to a STAT News report. The system was trained on 42,000 computed tomography scans taken in a National Institutes of Health clinical trial, according to the report. […]
Masimo touts hemoglobin monitoring study, wins FDA nod for Radius PPG
Masimo (NSDQ:MASI) recently touted results from a study of its SpHb monitoring tech exploring its ability to detect possible anemia in patients undergoing spine or cytoreductive surgery, and said it won FDA 510(k) clearance for its Radius PPG tetherless sensor. The Irvine, Calif.-based company said that results from its SpHb tech were published in the journal […]
Owlstone, Actelion ink collab pulmonary hypertension breath test dev deal
Owlstone Medical said today that it inked a strategic collaborative deal with Johnson & Johnson‘s (NYSE:JNJ) Actelion to discover and validate a breath-based test intended for the early diagnosis of pulmonary hypertension and its subtypes. Cambridge, UK-based Owlstone Medical said that the collaborative development program will be funded solely by Actelion, and that it will initially […]
J&J’s Auris touts prelim data from first-in-human study of Monarch platform
Johnson & Johnson‘s (NYSE:JNJ) subsidiary Auris Health today released preliminary results from a first-in-human feasibility study of its Monarch robotic interventional platform, which has FDA clearance for diagnostic and therapeutic bronchoscopic procedures. Preliminary data from the Benefit study of the Monarch platform was presented by Dr. Alexander Chen at the American Thoracic Society’s 2019 conference […]
Safety board OK’s continuing trial of ALung’s Hemolung RAS device
ALung Technologies said yesterday that it won approval from an independent Data and Safety Monitoring board to continue the U.S.-based VENT-AVOID clinical trial of its low-flow extracorporeal carbon dioxide removal technology intended to treat COPD patients with acute respiratory failure. The Pittsburgh-based company said that the VENT-AVOID trial looks to validate the safety and efficacy […]
Pulmonx raises $65m, taps Sung as CFO
Pulmonx said today that it raised $65 million in an oversubscribed equity round and added that it picked up Derrick Sung as its new chief financial officer. Funding in the round was lead by Ally Bridge Group and joined by newly invested RTW Investments, ArrowMark Partners, Driehaus Capital Management and existing investors, the Redwood City, […]
Innoviva-GSK project Trelegy Ellipta meets main endpoint in asthma pivotal trial
A combination drug-device therapy developed by GlaxoSmithKline(NYSE:GSK) and Innoviva (NSDQ:INVA) for asthma, Trelegy Ellipta, met the primary endpoint in its pivotal trial, the companies said last week. The Trelegy Ellipta inhaler is designed to deliver a single daily dose of three drugs – fluticasone furoate, umeclidinium and vilanterol – to patients with uncontrolled asthma. The 2,436-patient Captain trial […]
FDA clears Xvivo’s lung transplant perfusion system
The FDA today granted premarket approval to Xvivo Perfusion for its Xvivo Perfusion system with Steen solution perfusate intended to temporarily ventilate, oxygenate and pump preservation solution through lungs intended for transplantation procedures. The system is designed for use with lungs initially thought to be unacceptable for transplant, and allows a transplant team to perform […]
Pulmatrix, Cipla Technologies ink deal for inhaled anti-fungal
Pulmatrix (NSDQ:PULM) said yesterday that it inked a deal with Cipla to co-develop and commercialize an inhaled iSperse formulation of the anti-fungal drug itraconazole, intended for treating allergic bronchopulmonary aspergillosis in asthma patients. Lexington, Mass.-based Pulmatrix said that it in the deal, Cipla’s Cipla Tech subsidiary will make an upfront payment of $22 million to Pulmatrix […]
- 1
- 2
- 3
- …
- 54
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube